SLN
Silence Therapeutics PLC
NASDAQ: SLN · HEALTHCARE · BIOTECHNOLOGY
$7.31
+2.81% today
Updated 2026-04-30
Market cap
$363.70M
P/E ratio
—
P/S ratio
650.63x
EPS (TTM)
$-1.89
Dividend yield
—
52W range
$4 – $8
Volume
0.4M
Silence Therapeutics PLC (SLN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |